176 related articles for article (PubMed ID: 16258420)
21. [Imatinib. An anticancer agents indicated in the treatment of chronic myeloid leukemia]].
Taéron C
Rev Infirm; 2004 Feb; (98):39-40. PubMed ID: 15042992
[No Abstract] [Full Text] [Related]
22. Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukemia.
Cho BS; Kim HJ; Lee S; Eom KS; Min WS; Lee JW; Kim CC
Eur J Haematol; 2007 Aug; 79(2):170-3. PubMed ID: 17608710
[TBL] [Abstract][Full Text] [Related]
23. Current and emerging treatment options in chronic myeloid leukemia.
Jabbour E; Cortes JE; Giles FJ; O'Brien S; Kantarjian HM
Cancer; 2007 Jun; 109(11):2171-81. PubMed ID: 17431887
[TBL] [Abstract][Full Text] [Related]
24. Trisomy 8 finding treatment of imatinib mesylate in chronic myeloid leukemia cases.
Tunca Y; Güran S
Exp Hematol; 2005 Feb; 33(2):151. PubMed ID: 15676207
[No Abstract] [Full Text] [Related]
25. Antituberculosis therapy and imatinib for chronic myeloid leukemia.
Sorà F; De Matteis S; Di Mario A; Maiuro G; Laurenti L; Chiusolo P; Ardito F; Leone G; Sica S
Clin Infect Dis; 2006 Nov; 43(9):1224. PubMed ID: 17029152
[No Abstract] [Full Text] [Related]
26. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.
Carella AM
Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645
[No Abstract] [Full Text] [Related]
27. Overcoming drug resistance in chronic myeloid leukemia.
Cortes J
Curr Opin Hematol; 2006 Mar; 13(2):79-86. PubMed ID: 16456373
[TBL] [Abstract][Full Text] [Related]
28. Imatinib in chronic myeloid leukemia.
Krause SW; Holler E
N Engl J Med; 2007 Apr; 356(17):1780; author reply 1780. PubMed ID: 17460235
[No Abstract] [Full Text] [Related]
29. [Attentive questions about treatment of chronic myelogenous leukemia with imatinib mesylate].
Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):433-5. PubMed ID: 17147242
[No Abstract] [Full Text] [Related]
30. Untreated essential thrombocythemia evolving to biphenotypic leukemia, Philadelphia chromosome positive with monosomy 7: response to imatinib and reduced-intensity allogeneic stem cell transplant.
Martin SE; DellaValla J
Leukemia; 2005 Jun; 19(6):1095-6. PubMed ID: 15789065
[No Abstract] [Full Text] [Related]
31. [Imatinib--en epoch-making new drug against chronic myeloid leukemia].
Lakartidningen; 2003 Jun; 100(26-27):2283. PubMed ID: 12872372
[No Abstract] [Full Text] [Related]
32. Introduction: CML in the imatinib era.
Hehlmann R
Best Pract Res Clin Haematol; 2009 Sep; 22(3):283-4. PubMed ID: 19959079
[No Abstract] [Full Text] [Related]
33. [Treatment of chronic myeloid leukemia with imatinib].
Ohnishi K
Gan To Kagaku Ryoho; 2011 May; 38(5):746-8. PubMed ID: 21702117
[No Abstract] [Full Text] [Related]
34. Treating children with chronic myeloid leukemia in the imatinib era: a therapeutic dilemma?
Thornley I; Perentesis JP; Davies SM; Smith FO; Champagne M; Lipton JM
Med Pediatr Oncol; 2003 Aug; 41(2):115-7. PubMed ID: 12825214
[No Abstract] [Full Text] [Related]
35. Chronic myelogenous leukaemia (CML): an update.
Kumar L
Natl Med J India; 2006; 19(5):255-63. PubMed ID: 17203680
[TBL] [Abstract][Full Text] [Related]
36. [Treatment strategies for chronic myeloid leukemia].
Jinnai I
Rinsho Ketsueki; 2005 Jan; 46(1):1-6. PubMed ID: 16708910
[No Abstract] [Full Text] [Related]
37. Mobilization of Ph chromosome-negative peripheral blood stem cells in a child with chronic myeloid leukemia after imatinib-induced complete molecular remission.
Woods-Swafford W; Vnencak-Jones CL; Loken MR; Manes B; Frangoul H
Pediatr Blood Cancer; 2008 Mar; 50(3):639-41. PubMed ID: 16927371
[TBL] [Abstract][Full Text] [Related]
38. Imatinib or transplant for chronic myeloid leukaemia?
Craddock C; Augustson B; Basu S
Lancet; 2003 Jul; 362(9378):173. PubMed ID: 12867130
[No Abstract] [Full Text] [Related]
39. Imatinib or transplant for chronic myeloid leukaemia?
Goldman J; Apperley J; Kanfer E; Olavarria E; Marin D
Lancet; 2003 Jul; 362(9378):172-3. PubMed ID: 12867128
[No Abstract] [Full Text] [Related]
40. Double Philadelphia-chromosome: a resistance factor on the imatinib mesylate therapy for chronic myeloid leukemia.
Otero L; Ornellas MH; Dobbin J; de Souza Fernandez T
Int J Lab Hematol; 2008 Aug; 30(4):346-8. PubMed ID: 18665834
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
